People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Turn Biotechnologies, Inc. | — | Biotech / Pharma | Series B | $29.1M | $293.6M | 2023 |
David Andres Gobel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Andres Gobel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Vittorio Andres Sebastiano | 1 | 1 |
| Marco Andres Quarta | 1 | 1 |
| Sergio Andres Ruiz-Chinchilla | 1 | 1 |
| Anja Andres Krammer | 1 | 1 |
| Ric Andres Peterson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.